Ask AI
DURGA 1
DURGA-1: Phase Ib/II Study of AZD0120, a BCMA/CD19 Dual-Targeting CAR T-Cell Therapy, in R/R MM

Released: December 09, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 09, 2025